Cryoablation in male patients with breast cancer: a case report
Authors: Sanvido, Vanessa Monteiro; Holmes, Dennis R; Bromberg, Silvio Eduardo; Waitzberg, Angela Flavia Logullo; Gomes, Jackeline Oliveira; Barbante, Leticia Galvao; Junior, Antonio Rahal; Tachibana, Bruna Mayumi Takaki; Socolowski, Luis Ricardo; da Silva, Leonard Medeiros; Cavalcanti, Alexandre Biasi; Nazario, Afonso Celso Pinto
Source journal: Journal of medical case reports (2026-08-28)
DOI: 10.1186/s13256-026-06513-x
Abstract
BACKGROUND: Male breast cancer is rare, and because of its low incidence, treatment strategies often rely on data extrapolated from female breast cancer. Cryoablation has emerged as a promising local treatment modality for breast cancer; however, published experience regarding its use in male breast cancer remains extremely limited. CASE PRESENTATION: This study includes two male patients with early-stage breast carcinoma who underwent cryoablation. The first case involved a 71-year-old Brazilian male with a 3 cm nodule in the left breast, confirmed by imaging as a suspicious 2.4 cm mass. A biopsy revealed invasive carcinoma of no special type. Cryoablation was performed under local anesthesia using a single probe and two freeze-thaw cycles, creating a 5.6 cm ice ball. The procedure was painless. Post-procedure MRI showed a non-enhancing nodule, suggesting a positive therapeutic response. The patient later underwent mastectomy, which confirmed no residual tumor. The second case involved a 75-year-old American male with a 1.3 cm subareolar lump in the right breast. Due to his history of renal failure and keloid formation, traditional surgery was deemed unsuitable, and cryoablation was chosen. The procedure achieved an ice-ball margin greater than 5 mm around the tumor. Post-treatment imaging, including PET/CT at 3 months, showed no residual cancer. At 20 months of follow-up, no clinical or imaging evidence of recurrence was observed; longer-term follow-up is ongoing. CONCLUSIONS: These two cases provide complementary evidence regarding the use of cryoablation in male breast cancer. Case 1 demonstrates the technical feasibility of the procedure with pathological confirmation of complete tumor ablation, whereas Case 2 illustrates the potential role of cryoablation as definitive local treatment in a carefully selected patient; however, complete tumor eradication could not be pathologically confirmed, because no post-ablation biopsy or surgical specimen was available. Although these findings are preliminary, they address an important gap in the literature and support further investigation of cryoablation as a minimally invasive treatment option for selected male patients with breast cancer.
Related topics
Related open access articles
- CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH COLORECTAL CANCER AND COVID-19 COINFECTION - CASE REPORT
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- The use of non-invasive ventilation (NIV) in the treatment of patients with COVID-19
- Application of Nanotechnology in Treatment of COVID-19
- Nano Platforms in Combatting COVID-19: Unveiling Antiviral Strategies and Challenges
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.